ClinicalTrials.gg
RecruitingNCT07712211Updated Jul 17, 2026

Association Between Pain Catastrophizing and PONV in Laparoscopic Cholecystectomy Patients

An observational study in Vomiting, Postoperative, Pain and Nausea and Vomiting, Postoperative, sponsored by Trabzon Kanuni Education and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-17.

Sponsored by Trabzon Kanuni Education and Research Hospital · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
64
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 96 studies in Postoperative Nausea and Vomiting with a site in Turkey — 22 open to participants now, 23 under way, none of them phase 3. Postoperative Nausea and Vomiting · Turkey.

Planned enrollment
22nd of 25
64 · median 100
Started
2026
with 11 others
Observational
25 of 96
9 open now
Primary completion
2026-07
later than 11 of 22 live
Registered
90th of 96
by date

Among the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey, this one is the 22nd largest by planned enrollment of the 25 observational ones that give a count, is one of 12 that started in 2026, is one of 25 observational ones, reaches primary completion later than 11 of the 22 other live ones, and was the 90th registered.

Postoperative Nausea and Vomiting

638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.

Browse Postoperative Nausea and Vomiting studies →

Open to participants now

22 of the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 66 Postoperative Nausea and Vomiting studies recruiting now, 22 (33%) set no upper age limit and 38 (58%) stop at 75 or younger; 15 take children under 18; 11 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Postoperative Nausea and Vomiting with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to explore whether patients' tendency to exaggerate or focus on pain (pain catastrophizing) is related to experiencing nausea and vomiting after surgery. The study will include patients undergoing laparoscopic cholecystectomy. Before surgery, patients will answer questions measuring pain catastrophizing and rate their pain during intravenous cannulation. Nausea and vomiting will be assessed at various times during the first 24 hours after surgery. The results may help better understand how psychological factors affect postoperative symptoms.

Read the detailed description

This study is designed as a prospective, cross-sectional, and observational study. The Pain Catastrophizing Scale (PCS) is a well-established self-report instrument developed to assess catastrophic thinking related to pain. It evaluates how individuals perceive and respond to pain, focusing on tendencies such as rumination, magnification, and feelings of helplessness. Evidence suggests that PCS is a strong predictor of pain intensity, independent of anxiety levels. In this study, the validated Turkish version of the Pain Catastrophizing Scale will be used.

Postoperative nausea, vomiting, and retching are common adverse events that can complicate recovery from anesthesia. Patients often perceive these symptoms as more distressing than postoperative pain, and they represent important outcomes affecting patient satisfaction and recovery.

The present study aims to investigate the relationship between pain perception during intravenous (IV) cannulation, pain catastrophizing levels, and postoperative nausea and vomiting. By evaluating numeric pain scores during IV access alongside PCS scores, this study seeks to explore whether preoperative pain perception and psychological factors are associated with the frequency of postoperative nausea and vomiting.

The findings of this study are expected to contribute to a better understanding of the role of psychological factors in postoperative symptoms and may help improve anesthesia practices by supporting more individualized, patient-centered perioperative care.

03

Conditions studied

  • Vomiting, Postoperative
  • Pain
  • Nausea and Vomiting, Postoperative
  • Pain Catastrophizing

Keywords

  • The Pain Catastrophizing Scale
  • Postoperative Nausea and Vomiting
  • Laparoscopic Cholecystectomy
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of patients undergoing elective laparoscopic cholecystectomy at Trabzon University Faculty of Medicine, Kanuni Training and Research Hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients aged 18-65 years
  • (ASA) physical status I-II-III
  • Scheduled for elective laparoscopic cholecystectomy
  • Able to provide

Exclusion criteria

Exclusion Criteria:

  • Age \<18 or >65 years
  • Emergency surgery
  • > III
  • Pregnancy
  • Chronic opioid use
  • Known drug allergy
  • Psychiatric disorders
  • Neurological diseases (central or peripheral neuropathy)
  • History of cerebrovascular disease (stroke)
  • Chronic renal disease
  • Chronic pulmonary disease
  • Patients who refuse to participate
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
64 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adult patients undergoing elective laparoscopic cholecystectomy

    Aged 18 to 65 years, American Society of Anesthesiologists (ASA) physical status of I, II, III; Patients scheduled for emergency surgery , those with significant systemic diseases (ASA \> III), pregnancy, chronic opioid use, psychiatric disorders, neurological diseases, chronic renal or pulmonary disease, or those who do not provide informed consent will be exclude

06

What researchers measure

Primary outcomes

  1. Incidence of postoperative nausea and vomiting (PONV)

    The primary outcome is the incidence of postoperative nausea and vomiting (PONV) according to preoperative Pain Catastrophizing Scale (PCS) scores. Patients will be evaluated for PONV at 0, 3, 6, 12, and 24 hours postoperatively. The relationship between PCS scores and the frequency of PONV will be analyzed.

    Time frame: Within 24 hours postoperatively

Secondary outcomes

  1. Association between IV cannulation pain and pain catastrophizing

    The secondary outcome is the relationship between pain experienced during intravenous (IV) cannulation and preoperative Pain Catastrophizing Scale (PCS) scores. Pain during IV access will be measured using a numeric rating scale (0-10). The association between IV pain scores and PCS scores will be analyzed

    Time frame: Preoperative period

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg. 1999 Sep;89(3):652-8. doi: 10.1097/00000539-199909000-00022. PubMed 10475299 ↗
  • Uğurlu M, Karakaş Uğurlu G, Erten Ş, Çayköylü A. Validity of Turkish form of Pain Catastrophizing Scale and modeling of the relationship between pain-related disability with pain intensity, cognitive, and emotional factors. Psychiatry and Clinical Psychopharmacology. 2017;27(2):189-196. doi:10.1080/24750573.2017.1322672
  • Borna S, Ho OA, Gomez-Cabello CA, Haider SA, Genovese A, Prabha S, Haider CR, Felton CL, McLeod CJ, Bruce CJ, Carter RE, Forte AJ. Impact of Demographics and Psychological Factors on Three-Day Postoperative Pain Perception Following Hand Surgery. J Clin Med. 2024 Dec 25;14(1):37. doi: 10.3390/jcm14010037. PubMed 39797119 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jul 2026, 6 months after the start.

Of 52 non-industry observational studies under Postoperative Nausea and Vomiting, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 37. This study's planned 6 months is below that.

Counting every sponsor, half of 52 studies reached it within 11 months; a quarter within 4 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2026
First posted
Jul 17, 2026
StartActual
Jan 15, 2026
Primary completionEst.
Jul 15, 2026
CompletionEst.
Apr 2027
Last update
Jul 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07712211
Lead sponsor
Trabzon Kanuni Education and Research Hospital
Responsible party
Sponsor
First posted
Jul 17, 2026
Start date
Jan 15, 2026
Primary completion
Jul 15, 2026 (estimated)
Completion
Apr 2027 (estimated)
Last update
Jul 17, 2026

Study contacts

sedanur sula
Contact
sulasedanur@gmail.com
+905424096196

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion